| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007084841A3 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 09/13/2007 | WO2007084697A3 Process for preparing a crystalline form of tegaserod maleate |
| 09/13/2007 | US20070213526 5-(2-thioxospiro[cyclohexane-1,3-[3H]-indol]-1-methyl-2-pyrrole-2-carbonitrile; treating with base in presence of solvent to form basic salt and converting it to purified form by treating with water, acid, or heat |
| 09/13/2007 | US20070213524 Reacting an oxirane with carbon monoxide (pressure < 125 psi) to yield a beta lactone; using a catalyst comprising a chromiuim complex of a (2-hydroxyphenyl)imino(1,2-phenylene)imino-)phenol having ligands of tetrahydrofuran and cobalt tetracarbonyl; lactonization; chemical ring expansion;glass reactor |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213373 Indazole derivatives as CRF antagonists |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213326 Substituted indole compounds and their use as 5-ht6 receptor modulators |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2643416A1 Aldolases, nucleic acids encoding them and methods for making and using them |
| 09/13/2007 | CA2642870A1 Improved prodrugs of cc-1065 analogs |
| 09/12/2007 | EP1832577A1 Improved prodrugs of CC-1065 analogs |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1831159A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831132A2 Resolution of racemic organic acids with (1s, 4s)-4[3,4-dichlorophenyl]-1,2,3,4- tetrahydro-n-methyl-1-naphthaloneamine |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | CN101035867A Cyanine compound and optical recording materials |
| 09/12/2007 | CN101035774A Modulators of CRTH-2 receptor activity for the treatment of prostaglandin D2 mediated diseases |
| 09/12/2007 | CN101035528A Carbazole and cyclopentaindole derivatives to treat infection with hepatitis C virus |
| 09/12/2007 | CN101035527A Methods of treating a disorder |
| 09/12/2007 | CN101033225A Process of preparing troipisetron |
| 09/11/2007 | US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 09/11/2007 | US7268162 Aloe-emodin derivatives and their use in the treatment of neoplasias |
| 09/11/2007 | US7268159 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease |
| 09/11/2007 | US7268157 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/11/2007 | US7268156 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment |
| 09/11/2007 | US7268147 For therapy of inflammatory, allergic and respiratory diseases |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/11/2007 | CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 09/07/2007 | WO2007101156A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives |
| 09/07/2007 | WO2007100894A2 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099934A1 Aliphatic amino acid labeled with stable isotope, method of inserting the same in target protein, and method of nmr conformation analysis of protein |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007099217A1 α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT |
| 09/07/2007 | WO2007099216A2 β-CRYSTALLINE FORM OF PERINDOPRIL ARGININE SALT, METHOD FOR MAKING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 09/07/2007 | WO2007098962A1 Sigma receptor compounds |
| 09/07/2007 | WO2007038684A3 Pyrrole derivatives as therapeutic compounds |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2643994A1 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 09/07/2007 | CA2643803A1 .beta. crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same |
| 09/07/2007 | CA2642931A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives |
| 09/07/2007 | CA2642180A1 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | CA2641145A1 Sigma receptor compounds |
| 09/07/2007 | CA2633069A1 New 3'-, 7-substituted indirubins and their applications |
| 09/06/2007 | US20070208180 Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208072 Maleate salt of tegaserod and crystalline forms thereof |
| 09/06/2007 | US20070208030 Tetrahydroindolone Derivatives for Treament of Neurological Conditions |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208004 Indol-1-yl-acetic acid derivatives |
| 09/06/2007 | US20070207984 Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives |
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/06/2007 | US20070207527 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors |
| 09/05/2007 | EP1829872A1 Processes for production of indole compounds |
| 09/05/2007 | EP1829862A1 Sigma receptor compounds |
| 09/05/2007 | EP1828258A1 N-substituted imides as polymerization initiators |
| 09/05/2007 | EP1828174A1 Azabicyclic muscarinic receptor antagonists |
| 09/05/2007 | EP1828126A1 Acid addition salts of muscarinic receptor antagonists |
| 09/05/2007 | EP1828125A1 Arylpiperazine derivatives and their use as ligangs selective of the dopamine d3 receptor |
| 09/05/2007 | EP1828124A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828092A1 Process and intermediate compounds useful in the preparation of statins |
| 09/05/2007 | EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031546A Isoindoline compounds and methods of making and using the same |
| 09/05/2007 | CN101031545A Isoindoline compounds and methods of their use |
| 09/05/2007 | CN101031544A Heterocyclic compounds and optical recording materials |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101029018A Carbazolyl-functional bi-beta-diketo derivative and its production |
| 09/05/2007 | CN101029017A Production indapamide |
| 09/05/2007 | CN100335462C Carbazole derivative and its application in electroluminescent device |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265197 Polyoxyalkene amine endcapped with trimellitic acid, reduces viscosity, improves gloss of inks, coatings, or cosmetics containing high concentration of laked pigments |
| 09/04/2007 | US7265148 Substituted pyrrole-indoles |
| 09/04/2007 | US7265147 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7264891 Stability, efficiency and color purity |
| 09/04/2007 | CA2271861C Heterocyclic metallocenes and polymerization catalysts |
| 08/30/2007 | WO2007098356A1 Congeners of milnacipran as monoamine re-uptake |
| 08/30/2007 | WO2007097504A1 Process for the preparation of highly optical pure carvedilol |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007095980A1 Modified amino acids |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 08/30/2007 | US20070203343 Cyanine Dye Labelling Reagents |
| 08/30/2007 | US20070203209 Useful indole compounds |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203118 Substituted tetrahydroisoquinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs |
| 08/30/2007 | DE102006007882A1 Cycloalkyl-phenylsubstituierte cyclische Ketoenole Cycloalkyl-substituted cyclic ketoenols |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/29/2007 | EP1826267A1 Novel halogenases |
| 08/29/2007 | EP1826245A1 Nonsolvated crystals of polymethine compound, process for production thereof and use of the crystals |
| 08/29/2007 | EP1826200A2 Oxime derivative, photopolymerisable composition, colour filter and process for producing the same |